A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Adocia
- Target Recruit Count
- 27
- Registration Number
- NCT03176524
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-09-26
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- Adocia
- Target Recruit Count
- 36
- Registration Number
- NCT02915250
- Locations
- 🇩🇪
Profil Mainz GmbH & Co.KG, Mainz, Germany
🇩🇪Profil GmbH, Neuss, Germany
A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- Adocia
- Target Recruit Count
- 36
- Registration Number
- NCT02739906
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
🇩🇪Profil Mainz GmbH & Co.KG, Mainz, Germany
An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-01-21
- Last Posted Date
- 2016-05-30
- Lead Sponsor
- Adocia
- Target Recruit Count
- 15
- Registration Number
- NCT02660502
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Adocia
- Target Recruit Count
- 80
- Registration Number
- NCT02562313
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- Adocia
- Target Recruit Count
- 51
- Registration Number
- NCT02562326
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
🇩🇪Profil Mainz GmbH & Co.KG, Mainz, Germany
A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Adocia
- Target Recruit Count
- 26
- Registration Number
- NCT02529293
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Adocia
- Target Recruit Count
- 36
- Registration Number
- NCT02528396
- Locations
- 🇩🇪
Profil GmbH, Neuss, Germany
Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-04
- Last Posted Date
- 2015-11-06
- Lead Sponsor
- Adocia
- Target Recruit Count
- 28
- Registration Number
- NCT02514954
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-04
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Adocia
- Target Recruit Count
- 24
- Registration Number
- NCT02514850
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
© Copyright 2024. All Rights Reserved by MedPath